COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers, WHO
Concerns exists that angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) increase susceptibility to coronavirus SARS CoV-2 (the viral agent that causes the disease COVID-19) and the likelihood of severe COVID-19 illness. Concerns are based on considerations of biological plausibility and observation that there is an overrepresentation of patients with hypertension and other cardiovascular comorbidities among COVID-19 patients who have poor outcomes.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Cardiology | Cardiovascular | Coronavirus | COVID-19 | Health | Heart | Hypertension | SARS